Expert opinion on management of Pityriasis capitis (dandruff) and related scalp conditions in clinical practice

Authors

  • Sanjiv Kandhari Department of Dermatology, Dr. Kandhari Skin Clinic, New Delhi, India
  • Dinesh Hawelia Department of Dermatology, Dr. Hawelia’s Skin Clinic, Kolkata, West Bengal, India
  • Manas Sen Department of Dermatology, Zenith Multispeciality Hospital, Kolkata, West Bengal, India
  • Pravin Banodkar Department of Dermatology, Skin Crest Clinic, Matunga East, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252078

Keywords:

Dandruff, Hair products, Pharmacotherapy, Seborrhoeic dermatitis, Scalp psoriasis, Tinea versicolor

Abstract

Dandruff and related scalp conditions, including seborrhoeic dermatitis (SD), scalp psoriasis, folliculitis, pityriasis versicolor (PV) and acne vulgaris (AV), are common globally. Dandruff, caused by Malassezia fungi, leads to excessive scalp skin shedding, whereas SD can vary in severity. Scalp psoriasis presents with chronic inflammation and scaly plaques. PV is a benign fungal infection that affects the trunk and neck, whereas AV primarily impacts the face and can also appear on the body. Both acne and dandruff are associated with imbalances in the skin and gut microbiome and altered immune responses. Treatments range from topical antifungals and anti-inflammatories to systemic therapies. The key active ingredients such as Selenium sulphide (SS), Zinc pyrithione (ZPT), Coal tar, Salicylic acid, Ketoconazole, Ciclopirox and Clobetasol are commonly employed in antidandruff formulations. Comparative studies suggest SS has a superior anti-dandruff effect compared with ZPT and coal tar. SS is effective against fungal infections, cost-efficient and has minimal side effects. In chronic and recurrent conditions, the use of SS in maintenance therapy can significantly lower treatment costs. This makes it a practical choice for long-term management. The current study presents the consensus statements derived from focused group discussions held across various regions of India between March and September 2023 concerning clinical strategies for the management of dandruff and related dermatological conditions.

Metrics

Metrics Loading ...

References

Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: A comprehensive review. J Clin Investig Dermatol. 2015;3(2):87. DOI: https://doi.org/10.13188/2373-1044.1000019

Chan C, Smith T, He Z, Garter C. The sequelae and moderators of influence of dandruff on mental health among mainland Chinese Adults. Clin Cosmet Investig Dermatol. 2024;17:1333-46. DOI: https://doi.org/10.2147/CCID.S459498

Dall’Oglio F, Nasca MR, Gerbino C, Micali G. An overview of the diagnosis and management of seborrheic dermatitis. Clin Cosmet Investig Dermatol. 2022;15:1537-48. DOI: https://doi.org/10.2147/CCID.S284671

Pierard GE, Ausma J, Henry F. A Pilot Study on Seborrheic Dermatitis Using Pramiconazole as a Potent Oral Anti-Malassezia Agent. Dermatology. 2007;214:162–9. DOI: https://doi.org/10.1159/000098577

Godse G, Godse K. Safety, Efficacy and attributes of 2.5% selenium sulfide shampoo in the treatment of dandruff: A single-center study. Cureus 2024;16(3):8778. DOI: https://doi.org/10.7759/cureus.57148

Rahmatollah S, Nasrin S, Gholamreza M. Liquorice 7% versus selenium sulfide 1% shampoos in the treatment of dandruff: a clinical trial. Iran J Dermatol. 2012;15(4):144-5.

Draelos ZD, Kenneally DC, Hodges LT, Billhimer W, Copas M, Margraf C. A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos. J Investig Dermatol Symp Proc 2005;10:201-4. DOI: https://doi.org/10.1111/j.1087-0024.2005.10127.x

Clavaud C, Jourdain R, Bar-Hen A, Tichit M, Bouchier C, Pouradier F, et al. Dandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalp. PLoS ONE. 2013;8(3):58203. DOI: https://doi.org/10.1371/journal.pone.0058203

Sheth U, Dande P. Pityriasis capitis: Causes, pathophysiology, current modalities and future approach. J Cosmet Dermatol. 2021;20(1):35-47. DOI: https://doi.org/10.1111/jocd.13488

Leung AK, Barankin B, Lam JM. Tinea versicolor: an updated review. Drugs Context. 2022;11:1–20. DOI: https://doi.org/10.7573/dic.2022-9-2

Cleveland Clinic.org. Malassezia (Pityrosporum) Folliculitis, 2022. Available at https://my.clevelandclinic.org/health/diseases/22833-pityrosporum-folliculitis Accessed on 4 February 2025.

Blakely K, Gooderham M. Management of scalp psoriasis: Current perspectives. Psoriasis Targets Ther. 2016;6:33-40. DOI: https://doi.org/10.2147/PTT.S85330

De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut–skin axis: Current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms 2021;9(2):353. DOI: https://doi.org/10.3390/microorganisms9020353

Cleveland Clinic.org. Seborrheic Dermatitis, 2020. Available at https://my.clevelandclinic.org/health/ diseases/14403-seborrheic-dermatitis. Accessed on 4 February 2025.

Tucker D, Masood S. Seborrheic dermatitis. Available at: https://www.ncbi.nlm.nih.gov. Accessed 11 November 2024.

Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985;13(6):947-51. DOI: https://doi.org/10.1016/S0190-9622(85)70243-5

Al-Hammadi A, Al-Ismaily A, Al-Ali S, Ramadurai R, Jain R, McKinley-Grant L, et al. Topical, biological and clinical challenges in the management of patients with acne vulgaris. Sultan Qaboos Univ Med J. 2016;16(2):152-60. DOI: https://doi.org/10.18295/squmj.2016.16.02.004

Mayo Clinic.org. Dandruff, 2023. Available at: hhttps://www.mayoclinic.org/diseases-conditions/ dandruff/diagnosis-treatment/drc-20353854 Accessed on 4 April 2025.

Elewski BE. Clinical diagnosis of common scalp disorders. J Investig Dermatol Symp Proc 2005;10(3):190-3. DOI: https://doi.org/10.1111/j.1087-0024.2005.10103.x

Nobles T, Harberger S, Krishnamurthy K. Cradle Cap. Available at: https://www.ncbi.nlm.nih.gov. Accessed on 11 November 2024.

Barve SS, Deshpande S, Dhawal PP. Cytotoxic, cytostatic and keratolytic activity of anti-dandruff shampoo formulations. Int J Res Dermatol. 2023;9(2):61-6. DOI: https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20230036

Surachmiati L, Saldi SRF, Lusianingtyas T, Bramono K. The mycological efficacy and safety of selenium sulfide 1.8% versus ketoconazole 2% shampoo in pityriasis versicolor: A double-blind randomized controlled trial. Germs. 2022;12(4):452-60. DOI: https://doi.org/10.18683/germs.2022.1351

Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):78.

Van Cutsem J, Van Gerven F, Fransen J, Schrooten P, Janssen PAJ. The in vitro antifungal activity of ketoconazole, zinc pyrithione and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J Am Acad Dermatol. 1990;22(6):993-8. DOI: https://doi.org/10.1016/0190-9622(90)70140-D

Rapaport M. A randomized, controlled clinical trial of four anti-dandruff shampoos. J Int Med Res. 1981;9(2):152-6. DOI: https://doi.org/10.1177/030006058100900213

Domínguez-Álvarez E, Rácz B, Marć MA, Jawad NM, Szemerédi N, Viktorová J, et al. Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents. Drug Resist Updat. 2022;63:100844. DOI: https://doi.org/10.1016/j.drup.2022.100844

Reeder NL, Kaplan J, Xu J, Youngquist RS, Wallace J, Hu P, et al. Zinc pyrithione inhibits yeast growth through copper influx and inactivation of iron-sulfur proteins. Antimicrob Agents Chemother. 2011;55(12):5753-60. DOI: https://doi.org/10.1128/AAC.00724-11

Braza TJ, Dicarlo JB, Soon SL, Mccall CO. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol. 2003;148(6):1242-4. DOI: https://doi.org/10.1046/j.1365-2133.2003.05383.x

Sawleshwarkar SN, Salgaonkar V, Oberai C. Multicenter, open-label, non-comparative study of a combination of polytar and zinc pyrithione shampoo in the management of dandruff. Indian J Dermatol Venereol Leprol. 2004;70(1):25-8.

Park M, Cho YJ, Lee YW, Jung WH. Genomic Multiplication and Drug Efflux Influence Ketoconazole Resistance in Malassezia restricta. Front Cell Infect Microbiol. 2020;10:19. DOI: https://doi.org/10.3389/fcimb.2020.00191

Kastarinen H, Oksanen T, Okokon EO, Kiviniemi VV, Airola K, Jyrkkä J, et al. Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database Syst Rev. 2014;2014(5):9446. DOI: https://doi.org/10.1002/14651858.CD009446.pub2

McGrath J, Murphy GM. The control of seborrhoeic dermatitis and dandruff by antipityrosporal drugs. Drugs. 1991;41(2):178-84. DOI: https://doi.org/10.2165/00003495-199141020-00003

Berk T, Scheinfeld N. Seborrheic dermatitis. Pharm Ther. 2010;35(6):348.

Długosz O, Ochnik M, Sochocka M, Franz D, Orzechowska B, Anna CK, et al. Antimicrobial and antiviral activity of selenium sulphide nanoparticles synthesised in extracts from spices in natural deep eutectic solvents (NDES). Sustain Mater Technol. 2022;32:433. DOI: https://doi.org/10.1016/j.susmat.2022.e00433

Massiot P, Clavaud C, Thomas M, Ott A, Guéniche A, Panhard S, et al. Continuous clinical improvement of mild‐to‐moderate seborrheic dermatitis and rebalancing of the scalp microbiome using a selenium disulfide–based shampoo after an initial treatment with ketoconazole. J Cosmet Dermatol. 2022;21(5):2215-25. DOI: https://doi.org/10.1111/jocd.14362

Barbosa V, Melo DF, Vañó-Galván S, Lutchmanen-Kolanthan V, Sant’Anna B, Leclerc-Mercier S, et al. A comparative randomized clinical study assessing the efficacy of a 1% selenium disulfide-based shampoo versus 2% ketoconazole shampoo in subjects with moderate to severe scalp seborrheic dermatitis. Skin Appendage Disord. 2024;1:8. DOI: https://doi.org/10.1159/000539209

Shuster S, Meynadier J, Kerl H, Nolting S. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% Ciclopirox shampoo. Arch Dermatol. 2005;141(1):67. DOI: https://doi.org/10.1001/archderm.141.1.47

Unholzer A, Varigos G, Nicholls D, Schinzel S, Nietsch KH, Ulbricht H, et al. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison. Infection. 2002;30(6):373-6. DOI: https://doi.org/10.1007/s15010-002-2196-9

Marks R, Pearse AD, Walker AP. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol. 1985;112(4):415-22. DOI: https://doi.org/10.1111/j.1365-2133.1985.tb02314.x

Kim GK, Rosso JD. Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis. J Clin Aesthet Dermatol. 2013;6(2):29-35.

Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol 2007;57(2):257-64. DOI: https://doi.org/10.1016/j.jaad.2006.11.007

Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: A review of the literature. 2005;44(5):355-60. DOI: https://doi.org/10.1111/j.1365-4632.2004.02186.x

Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: Results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 1995;132(3):441-5. DOI: https://doi.org/10.1111/j.1365-2133.1995.tb08680.x

Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Physiol. 2002;15(6):434-41. DOI: https://doi.org/10.1159/000066452

Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatol Treat. 2007;18(2):88-96. DOI: https://doi.org/10.1080/16537150601092944

Hammoudi Halat D, Younes S, Mourad N, Rahal M. Allylamines, benzylamines and fungal cell permeability: a review of mechanistic effects and usefulness against fungal pathogens. Membranes. 2022;12(12):1171. DOI: https://doi.org/10.3390/membranes12121171

Nahm WK, Orengo I, Rosen T. The antifungal agent butenafine manifests anti-inflammatory activity in vivo. J Am Acad Dermatol. 1999;41(2):203-6. DOI: https://doi.org/10.1016/S0190-9622(99)70049-6

Josse G, Rouvrais C, Mas A, Haftek M, Delalleau A, Ferraq Y, et al. A multi-technique evaluation of topical corticosteroid treatment. Skin Res Technol. 2009;15(1):35-9. DOI: https://doi.org/10.1111/j.1600-0846.2008.00326.x

Wikler JR, Nieboer C, Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol. 1992;27(1):37-9. DOI: https://doi.org/10.1016/0190-9622(92)70153-7

Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrheic dermatitis – A double-blind study. Dermatology. 2001;202(1):35-7. DOI: https://doi.org/10.1159/000051582

El‐Gothamy Z, Ghozzi M. Tinea versicolor of the scalp. Int J Dermatol. 1995;34(8):533-4. DOI: https://doi.org/10.1111/j.1365-4362.1995.tb02946.x

Hernanz A del P, Vicente SD, Ramos FM, Belaustegui ARN. Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor. Rev Infect Dis. 1987;9:121-7. DOI: https://doi.org/10.1093/clinids/9.Supplement_1.S121

Gupta AK, Lyons DC. Pityriasis versicolor: an update on pharmacological treatment options. Expert Opin Pharmacother. 2014;15(12):1707-13. DOI: https://doi.org/10.1517/14656566.2014.931373

Bruni F, Alessandrini A, Starace M, Orlando G, Piraccini BM. Clinical and trichoscopic features in various forms of scalp psoriasis. J Eur Acad Dermatol Venereol. 2021;35(9):1830-7. DOI: https://doi.org/10.1111/jdv.17354

Rubenstein RM, Malerich SA. Malassezia (pityrosporum) folliculitis. J Clin Aesthet Dermatol. 2014;7(3):37-41.

Barrera-Godínez A, Figueroa-Ramos G. Malassezia folliculitis in the setting of COVID-19. Curr Fungal Infect Rep. 2023;17(1):71-6. DOI: https://doi.org/10.1007/s12281-023-00450-8

Torsekar R, Gautam M. Topical therapies in psoriasis. Indian Dermatol Online J. 2017;8(4):235. DOI: https://doi.org/10.4103/2229-5178.209622

Borglund E, Enhamre A. Treatment of psoriasis with topical selenium sulphide. Br J Dermatol. 1987;117(5):665-6. DOI: https://doi.org/10.1111/j.1365-2133.1987.tb07503.x

Rathi S. Acne vulgaris treatment: The current scenario. Indian J Dermatol. 2011;56(1):7. DOI: https://doi.org/10.4103/0019-5154.77543

Wikanto JR, Wijaya L, Astiarani Y, Regina R. Haircare practice and dandruff problems among Indonesian medical students. J Gen Proced Dermatol Venereol Indones. 2022:6(2);1-5. DOI: https://doi.org/10.7454/jdvi.v06i02.1000

Gavazzoni Dias MF, De Almeida A, Cecato P, Adriano A, Pichler J. The shampoo pH can affect the hair: Myth or reality. Int J Trichol 2014;6(3):95. DOI: https://doi.org/10.4103/0974-7753.139078

Nayak Bs, Ann C, Azhar A, Ling ES, Yen W, Aithal Pa. A study on scalp hair health and hair care practices among Malaysian medical students. Int J Trichol. 2017;9(2):58. DOI: https://doi.org/10.4103/ijt.ijt_76_16

Fernández-Peña L, Guzmán E. Physicochemical aspects of the performance of hair-conditioning formulations. Cosmetics. 2020;7(2):26. DOI: https://doi.org/10.3390/cosmetics7020026

Downloads

Published

2025-06-27

How to Cite

Kandhari, S., Hawelia, D., Sen, M., & Banodkar, P. (2025). Expert opinion on management of Pityriasis capitis (dandruff) and related scalp conditions in clinical practice. International Journal of Research in Dermatology, 11(4), 359–369. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252078

Issue

Section

Review Articles